Cytokinetics, Incorporated (CYTK)
NASDAQ: CYTK · Real-Time Price · USD
37.01
+0.42 (1.15%)
At close: Jul 11, 2025, 4:00 PM
37.09
+0.08 (0.22%)
After-hours: Jul 11, 2025, 7:45 PM EDT
Cytokinetics Analyst Ratings
Total Analysts
14
Consensus Rating
Buy
Price Target
$70.92
Upside
+91.62%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JP Morgan | JP Morgan | Buy Maintains $71 → $53 | Buy | Maintains | $71 → $53 | +43.20% | Jun 9, 2025 |
| Mizuho | Mizuho | Buy Maintains $103 → $84 | Buy | Maintains | $103 → $84 | +126.97% | May 29, 2025 |
| Needham | Needham | Strong Buy Reiterates $72 | Strong Buy | Reiterates | $72 | +94.54% | May 14, 2025 |
| Barclays | Barclays | Buy Maintains $55 → $53 | Buy | Maintains | $55 → $53 | +43.20% | May 8, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $82 → $80 | Buy | Maintains | $82 → $80 | +116.16% | May 7, 2025 |
| Citigroup | Citigroup | Strong Buy Maintains $86 → $80 | Strong Buy | Maintains | $86 → $80 | +116.16% | May 7, 2025 |
| UBS | UBS | Hold Maintains $47 → $41 | Hold | Maintains | $47 → $41 | +10.78% | May 2, 2025 |
| Needham | Needham | Strong Buy Reiterates $72 | Strong Buy | Reiterates | $72 | +94.54% | May 2, 2025 |
| Barclays | Barclays | Buy Initiates $55 | Buy | Initiates | $55 | +48.61% | Apr 24, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $120 | Strong Buy | Reiterates | $120 | +224.24% | Apr 21, 2025 |
| B of A Securities | B of A Securities | Hold Maintains $62 → $54 | Hold | Maintains | $62 → $54 | +45.91% | Apr 15, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $120 | Strong Buy | Reiterates | $120 | +224.24% | Apr 15, 2025 |
| JMP Securities | JMP Securities | Buy Reiterates $78 | Buy | Reiterates | $78 | +110.75% | Apr 10, 2025 |
| Needham | Needham | Strong Buy Reiterates $72 | Strong Buy | Reiterates | $72 | +94.54% | Apr 8, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $120 | Strong Buy | Reiterates | $120 | +224.24% | Apr 4, 2025 |
| Citizens Capital Markets | Citizens Capital Markets | Buy Reiterates $78 | Buy | Reiterates | $78 | +110.75% | Apr 3, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.